.Merck defeats incomes expectations, brings up purchases overview on powerful requirement for leading medications like Keytruda CNBCMerck & Co. (MRK US) Trumps Earnings Projections as Keytruda Purchases Increase BloombergMerck Supply: Pharma Titan Posts Powerful Outcomes, However Outlook Falls Short Entrepreneur's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats income and also sales expectations amid Keytruda strong point, however delivers mixed full-year expectation MarketWatch.